These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 10467717)
1. Overview of endocrine disruptor research activity in the United States. Kavlock RJ Chemosphere; 1999 Oct; 39(8):1227-36. PubMed ID: 10467717 [TBL] [Abstract][Full Text] [Related]
2. The U.S. federal framework for research on endocrine disruptors and an analysis of research programs supported during fiscal year 1996. Reiter LW; DeRosa C; Kavlock RJ; Lucier G; Mac MJ; Melillo J; Melnick RL; Sinks T; Walton BT Environ Health Perspect; 1998 Mar; 106(3):105-13. PubMed ID: 9443998 [TBL] [Abstract][Full Text] [Related]
4. Endocrine disruptors and reproductive development: a weight-of-evidence overview. Cooper RL; Kavlock RJ J Endocrinol; 1997 Feb; 152(2):159-66. PubMed ID: 9071972 [TBL] [Abstract][Full Text] [Related]
5. Selecting appropriate animal models and experimental designs for endocrine disruptor research and testing studies. Stokes WS ILAR J; 2004; 45(4):387-93. PubMed ID: 15454677 [TBL] [Abstract][Full Text] [Related]
6. Risk management frameworks for human health and environmental risks. Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953 [TBL] [Abstract][Full Text] [Related]
7. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Kavlock RJ; Daston GP; DeRosa C; Fenner-Crisp P; Gray LE; Kaattari S; Lucier G; Luster M; Mac MJ; Maczka C; Miller R; Moore J; Rolland R; Scott G; Sheehan DM; Sinks T; Tilson HA Environ Health Perspect; 1996 Aug; 104 Suppl 4(Suppl 4):715-40. PubMed ID: 8880000 [TBL] [Abstract][Full Text] [Related]
8. Use of the laboratory rat as a model in endocrine disruptor screening and testing. Gray LE; Wilson V; Noriega N; Lambright C; Furr J; Stoker TE; Laws SC; Goldman J; Cooper RL; Foster PM ILAR J; 2004; 45(4):425-37. PubMed ID: 15454681 [TBL] [Abstract][Full Text] [Related]
9. In vitro models in endocrine disruptor screening. Charles GD ILAR J; 2004; 45(4):494-501. PubMed ID: 15454688 [TBL] [Abstract][Full Text] [Related]
10. Endocrine disrupting chemicals research program of the U.S. Environmental Protection Agency: summary of a peer-review report. Harding AK; Daston GP; Boyd GR; Lucier GW; Safe SH; Stewart J; Tillitt DE; Van Der Kraak G Environ Health Perspect; 2006 Aug; 114(8):1276-82. PubMed ID: 16882539 [TBL] [Abstract][Full Text] [Related]
11. FIFRA Subdivision F testing Guidelines: are these tests adequate to detect potential hormonal activity for crop protection chemicals? Federal Insecticide, Fungicide, and Rodenticide Act. Stevens JT; Tobia A; Lamb JC; Tellone C; O'Neal F J Toxicol Environ Health; 1997 Apr; 50(5):415-31. PubMed ID: 9140462 [TBL] [Abstract][Full Text] [Related]
12. Ecological risk assessment of endocrine disruptors. Hutchinson TH; Brown R; Brugger KE; Campbell PM; Holt M; Länge R; McCahon P; Tattersfield LJ; van Egmond R Environ Health Perspect; 2000 Nov; 108(11):1007-14. PubMed ID: 11102288 [TBL] [Abstract][Full Text] [Related]
13. Mysid crustaceans as potential test organisms for the evaluation of environmental endocrine disruption: a review. Verslycke TA; Fockedey N; McKenney CL; Roast SD; Jones MB; Mees J; Janssen CR Environ Toxicol Chem; 2004 May; 23(5):1219-34. PubMed ID: 15180373 [TBL] [Abstract][Full Text] [Related]
14. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations. Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663 [TBL] [Abstract][Full Text] [Related]
15. Environmental endocrine disruption: an effects assessment and analysis. Crisp TM; Clegg ED; Cooper RL; Wood WP; Anderson DG; Baetcke KP; Hoffmann JL; Morrow MS; Rodier DJ; Schaeffer JE; Touart LW; Zeeman MG; Patel YM Environ Health Perspect; 1998 Feb; 106 Suppl 1(Suppl 1):11-56. PubMed ID: 9539004 [TBL] [Abstract][Full Text] [Related]
16. OECD test strategies and methods for endocrine disruptors. Gelbke HP; Kayser M; Poole A Toxicology; 2004 Dec; 205(1-2):17-25. PubMed ID: 15458786 [TBL] [Abstract][Full Text] [Related]
18. The use and acceptance of Other Scientifically Relevant Information (OSRI) in the U.S. Environmental Protection Agency (EPA) Endocrine Disruptor Screening Program. Bishop PL; Willett CE Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):3-22. PubMed ID: 24151143 [TBL] [Abstract][Full Text] [Related]
19. Are all EDC effects mediated via steroid hormone receptors? Fisher JS Toxicology; 2004 Dec; 205(1-2):33-41. PubMed ID: 15458788 [TBL] [Abstract][Full Text] [Related]
20. Failure to Launch: The Endocrine Disruptor Screening Program at the U.S. Environmental Protection Agency. Maffini MV; Vandenberg LN Front Toxicol; 2022; 4():908439. PubMed ID: 35707496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]